VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q77292038  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000103.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q77292038‏
024 ‎‡a  0000-0002-1557-1856‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q77292038‏
100 0 ‎‡a  M G Scott‏ ‎‡c  researcher‏ ‎‡9  en‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  M G Scott‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's A biosensor to monitor dynamic regulation and function of tumour suppressor PTEN in living cells‏
670 ‎‡a  Author's Arrestins as Regulatory Hubs in Cancer Signalling Pathways‏
670 ‎‡a  Author's beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53.‏
670 ‎‡a  Author's Beta-arrestins operate an on/off control switch for focal adhesion kinase activity‏
670 ‎‡a  Author's Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins.‏
670 ‎‡a  Author's CXCR7 participates in CXCL12-induced CD34+ cell cycling through β-arrestin-dependent Akt activation.‏
670 ‎‡a  Author's Distinct functional outputs of PTEN signalling are controlled by dynamic association with β-arrestins.‏
670 ‎‡a  Author's Evidence for internal stores of CCR5 in blood cells‏
670 ‎‡a  Author's Identification of novel polymorphisms within the promoter region of the human beta2 adrenergic receptor gene.‏
670 ‎‡a  Author's Methods to Investigate the Nucleocytoplasmic Shuttling Properties of β-Arrestins‏
670 ‎‡a  Author's Posttranslational Regulation and Conformational Plasticity of PTEN‏
670 ‎‡a  Author's PTEN controls glandular morphogenesis through a juxtamembrane β-Arrestin1/ARHGAP21 scaffolding complex‏
670 ‎‡a  Author's Rapid Detection of Dynamic PTEN Regulation in Living Cells Using Intramolecular BRET.‏
670 ‎‡a  Author's Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.‏
670 ‎‡a  Author's Strength of Neisseria meningitidis binding to endothelial cells requires highly-ordered CD147/β2-adrenoceptor clusters assembled by alpha-actinin-4.‏
670 ‎‡a  Author's Targeting of beta-arrestin2 to the centrosome and primary cilium: role in cell proliferation control‏
670 ‎‡a  Author's Targeting PTEN in Colorectal Cancers‏
670 ‎‡a  Author's Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.‏
670 ‎‡a  Author's The C-terminus region of β-arrestin1 modulates VE-cadherin expression and endothelial cell permeability.‏
670 ‎‡a  Author's The Conserved Isoleucine-Valine-Phenylalanine Motif Couples Activation State and Endocytic Functions of β-Arrestins‏
670 ‎‡a  Author's [The unrestrained expansion of beta-arrestin functions spread to development]‏
670 ‎‡a  Author's β-Arrestins: Multitask Scaffolds Orchestrating the Where and When in Cell Signalling‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/viaf/300056585‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/SUDOC|164749365‏
909 ‎‡a  (orcid) 0000000215571856‏ ‎‡9  1‏
919 ‎‡a  βarrestinsmultitaskscaffoldsorchestratingthewhereandwhenincellsignalling‏ ‎‡A  β-Arrestins: Multitask Scaffolds Orchestrating the Where and When in Cell Signalling‏ ‎‡9  1‏
919 ‎‡a  unrestrainedexpansionofbetaarrestinfunctionsspreadtodevelopment‏ ‎‡A  [The unrestrained expansion of beta-arrestin functions spread to development]‏ ‎‡9  1‏
919 ‎‡a  rapiddetectionofdynamicptenregulationinlivingcellsusingintramolecularbret‏ ‎‡A  Rapid Detection of Dynamic PTEN Regulation in Living Cells Using Intramolecular BRET.‏ ‎‡9  1‏
919 ‎‡a  receptorsequestrationinresponsetoβarrestin2phosphorylationbyerk12governssteadystatelevelsofgpcrcellsurfaceexpression‏ ‎‡A  Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.‏ ‎‡9  1‏
919 ‎‡a  conservedisoleucinevalinephenylalaninemotifcouplesactivationstateandendocyticfunctionsofβarrestins‏ ‎‡A  The Conserved Isoleucine-Valine-Phenylalanine Motif Couples Activation State and Endocytic Functions of β-Arrestins‏ ‎‡9  1‏
919 ‎‡a  100terminusregionofβarrestin1modulatesvecadherinexpressionandendothelialcellpermeability‏ ‎‡A  The C-terminus region of β-arrestin1 modulates VE-cadherin expression and endothelial cell permeability.‏ ‎‡9  1‏
919 ‎‡a  targetingspare200chemokinereceptor5ccr5asaprincipletoinhibithiv1entry‏ ‎‡A  Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.‏ ‎‡9  1‏
919 ‎‡a  targetingptenincolorectalcancers‏ ‎‡A  Targeting PTEN in Colorectal Cancers‏ ‎‡9  1‏
919 ‎‡a  targetingofbetaarrestin2tothecentrosomeandprimaryciliumroleincellproliferationcontrol‏ ‎‡A  Targeting of beta-arrestin2 to the centrosome and primary cilium: role in cell proliferation control‏ ‎‡9  1‏
919 ‎‡a  strengthofneisseriameningitidisbindingtoendothelialcellsrequireshighlyorderedcd147β2adrenoceptorclustersassembledbyalphaactinin4‏ ‎‡A  Strength of Neisseria meningitidis binding to endothelial cells requires highly-ordered CD147/β2-adrenoceptor clusters assembled by alpha-actinin-4.‏ ‎‡9  1‏
919 ‎‡a  biosensortomonitordynamicregulationandfunctionoftumoursuppressorpteninlivingcells‏ ‎‡A  A biosensor to monitor dynamic regulation and function of tumour suppressor PTEN in living cells‏ ‎‡9  1‏
919 ‎‡a  arrestinsasregulatoryhubsincancersignallingpathways‏ ‎‡A  Arrestins as Regulatory Hubs in Cancer Signalling Pathways‏ ‎‡9  1‏
919 ‎‡a  betaarrestin2oligomerizationcontrolsthemdm2dependentinhibitionofp53‏ ‎‡A  beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53.‏ ‎‡9  1‏
919 ‎‡a  betaarrestinsoperateanonoffcontrolswitchforfocaladhesionkinaseactivity‏ ‎‡A  Beta-arrestins operate an on/off control switch for focal adhesion kinase activity‏ ‎‡9  1‏
919 ‎‡a  cooperativeregulationofextracellularsignalregulatedkinaseactivationandcellshapechangebyfilaminaandbetaarrestins‏ ‎‡A  Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins.‏ ‎‡9  1‏
919 ‎‡a  cxcr7participatesincxcl12inducedcd34+cellcyclingthroughβarrestindependentaktactivation‏ ‎‡A  CXCR7 participates in CXCL12-induced CD34+ cell cycling through β-arrestin-dependent Akt activation.‏ ‎‡9  1‏
919 ‎‡a  distinctfunctionaloutputsofptensignallingarecontrolledbydynamicassociationwithβarrestins‏ ‎‡A  Distinct functional outputs of PTEN signalling are controlled by dynamic association with β-arrestins.‏ ‎‡9  1‏
919 ‎‡a  evidenceforinternalstoresofccr5inbloodcells‏ ‎‡A  Evidence for internal stores of CCR5 in blood cells‏ ‎‡9  1‏
919 ‎‡a  identificationofnovelpolymorphismswithinthepromoterregionofthehumanbeta2adrenergicreceptorgene‏ ‎‡A  Identification of novel polymorphisms within the promoter region of the human beta2 adrenergic receptor gene.‏ ‎‡9  1‏
919 ‎‡a  methodstoinvestigatethenucleocytoplasmicshuttlingpropertiesofβarrestins‏ ‎‡A  Methods to Investigate the Nucleocytoplasmic Shuttling Properties of β-Arrestins‏ ‎‡9  1‏
919 ‎‡a  posttranslationalregulationandconformationalplasticityofpten‏ ‎‡A  Posttranslational Regulation and Conformational Plasticity of PTEN‏ ‎‡9  1‏
919 ‎‡a  ptencontrolsglandularmorphogenesisthroughajuxtamembraneβarrestin1arhgap21scaffoldingcomplex‏ ‎‡A  PTEN controls glandular morphogenesis through a juxtamembrane β-Arrestin1/ARHGAP21 scaffolding complex‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  ISNI|0000000025565885
996 ‎‡2  LC|n 90652857
996 ‎‡2  KRNLK|KAC200813550
996 ‎‡2  LC|nr 98006527
996 ‎‡2  LC|n 92102658
996 ‎‡2  NTA|071468730
996 ‎‡2  LC|nb2013012493
996 ‎‡2  DNB|134518128
996 ‎‡2  NTA|069481881
996 ‎‡2  LC|n 97125046
996 ‎‡2  LC|n 87882748
996 ‎‡2  LC|n 82225012
996 ‎‡2  BNE|XX4607016
996 ‎‡2  NKC|xx0188835
996 ‎‡2  DNB|1030599173
996 ‎‡2  DNB|1282103202
996 ‎‡2  LC|n 88222135
996 ‎‡2  LC|n 88222138
996 ‎‡2  LC|n 00068443
996 ‎‡2  ISNI|0000000028194549
996 ‎‡2  NKC|osd20211121766
996 ‎‡2  DBC|87097969687520
996 ‎‡2  LIH|LNB:CA_r__o_;=B1
996 ‎‡2  SUDOC|233658262
996 ‎‡2  ISNI|0000000117424289
996 ‎‡2  J9U|987007350723505171
996 ‎‡2  ISNI|0000000448838208
996 ‎‡2  ISNI|0000000500268696
996 ‎‡2  LC|n 84123769
996 ‎‡2  BIBSYS|1701934215505
996 ‎‡2  NTA|193449943
996 ‎‡2  LC|n 2003118325
996 ‎‡2  ISNI|0000000044041091
996 ‎‡2  CAOONL|ncf11354540
996 ‎‡2  NTA|072444290
996 ‎‡2  NUKAT|n 2013051873
996 ‎‡2  BIBSYS|90241251
996 ‎‡2  BNF|14043713
996 ‎‡2  N6I|vtls000012141
996 ‎‡2  ISNI|0000000024766482
996 ‎‡2  NLA|000035208892
996 ‎‡2  DNB|1325486221
996 ‎‡2  PLWABN|9810546424405606
996 ‎‡2  DNB|1138734160
996 ‎‡2  DNB|172529409
996 ‎‡2  ISNI|0000000038696091
996 ‎‡2  NUKAT|n 2013202086
996 ‎‡2  ISNI|0000000110007466
996 ‎‡2  ISNI|0000000026440785
996 ‎‡2  ISNI|0000000075551916
996 ‎‡2  PLWABN|9813692753905606
996 ‎‡2  NUKAT|n 2007002499
996 ‎‡2  ISNI|000000040833112X
996 ‎‡2  ISNI|0000000408610321
996 ‎‡2  NTA|306225174
996 ‎‡2  NTA|069633495
996 ‎‡2  SIMACOB|395465219
996 ‎‡2  NUKAT|n 2010143445
996 ‎‡2  BIBSYS|11008363
996 ‎‡2  NTA|142893137
996 ‎‡2  ISNI|0000000382734691
996 ‎‡2  BLBNB|000347467
996 ‎‡2  DNB|1044914637
996 ‎‡2  LC|n 85809516
996 ‎‡2  NII|DA00278506
996 ‎‡2  NTA|315587814
996 ‎‡2  LC|no2016166225
996 ‎‡2  LC|no2022148439
996 ‎‡2  ISNI|0000000394476765
996 ‎‡2  RERO|A011991418
996 ‎‡2  ISNI|0000000117004508
996 ‎‡2  LC|n 91003668
996 ‎‡2  RERO|A003816284
996 ‎‡2  RERO|A003816287
996 ‎‡2  RERO|A003816286
996 ‎‡2  RERO|A003816283
996 ‎‡2  RERO|A003816282
996 ‎‡2  ISNI|000000035995096X
996 ‎‡2  RERO|A003816288
996 ‎‡2  SUDOC|030021065
996 ‎‡2  LC|n 2010072595
996 ‎‡2  B2Q|0000125013
996 ‎‡2  LC|nb2011015109
996 ‎‡2  CAOONL|ncf10049662
996 ‎‡2  CAOONL|ncf10264432
996 ‎‡2  NDL|001310342
996 ‎‡2  LC|n 00076488
996 ‎‡2  NTA|099099039
996 ‎‡2  LC|n 2004071498
996 ‎‡2  W2Z|4018083
996 ‎‡2  LC|n 81029073
996 ‎‡2  LC|n 2022005668
996 ‎‡2  LC|nb2005017041
996 ‎‡2  ISNI|0000000440013834
996 ‎‡2  J9U|987007463640505171
996 ‎‡2  RERO|A025495663
996 ‎‡2  LC|nb2001031571
996 ‎‡2  ISNI|0000000066765816
996 ‎‡2  CAOONL|ncf10409757
996 ‎‡2  LC|n 86133605
996 ‎‡2  LC|n 2015019740
996 ‎‡2  W2Z|1675321645628
996 ‎‡2  J9U|987007426073205171
996 ‎‡2  LC|nb2012007987
996 ‎‡2  LC|no2017026375
996 ‎‡2  LC|n 89659146
996 ‎‡2  SUDOC|11917569X
996 ‎‡2  NTA|27340489X
996 ‎‡2  NKC|xx0302297
996 ‎‡2  ERRR|11831649
996 ‎‡2  BNF|17786508
996 ‎‡2  LC|no2015125776
996 ‎‡2  BNF|16660477
996 ‎‡2  NTA|268943710
996 ‎‡2  LC|no2021024407
996 ‎‡2  NII|DA04561054
996 ‎‡2  SUDOC|203810929
996 ‎‡2  DNB|1026504619
996 ‎‡2  LC|no2019021701
996 ‎‡2  CAOONL|ncf11874334
996 ‎‡2  NUKAT|n 2005141029
996 ‎‡2  NII|DA05138118
996 ‎‡2  NLA|000035907049
996 ‎‡2  BNF|14225689
996 ‎‡2  J9U|987012501638105171
996 ‎‡2  CAOONL|ncf10582441
996 ‎‡2  ISNI|0000000045618737
996 ‎‡2  N6I|vtls000116322
996 ‎‡2  LC|no2014012489
996 ‎‡2  NKC|jcu20201074506
996 ‎‡2  SUDOC|233810730
996 ‎‡2  BNF|14699628
996 ‎‡2  ISNI|0000000106787308
996 ‎‡2  BNF|12152266
996 ‎‡2  BAV|495_225175
996 ‎‡2  DNB|1041249543
996 ‎‡2  ISNI|0000000039505840
996 ‎‡2  DNB|1154414213
996 ‎‡2  JPG|500020478
996 ‎‡2  LC|nb2010000496
996 ‎‡2  CAOONL|ncf10141021
996 ‎‡2  JPG|500032332
996 ‎‡2  DBC|87097947511208
996 ‎‡2  BIBSYS|99022700
996 ‎‡2  DNB|12972288X
996 ‎‡2  ISNI|0000000450493915
996 ‎‡2  RERO|A024205338
996 ‎‡2  ISNI|0000000095145480
996 ‎‡2  LC|n 88605031
996 ‎‡2  LC|nb2014025477
996 ‎‡2  NDL|00900774
996 ‎‡2  CAOONL|ncf10160354
996 ‎‡2  DNB|1208305786
996 ‎‡2  NLA|000035892105
996 ‎‡2  BIBSYS|1579001847700
996 ‎‡2  SUDOC|107952254
996 ‎‡2  NUKAT|n 2017210315
996 ‎‡2  DNB|134518136
996 ‎‡2  LC|nr2005007515
996 ‎‡2  PTBNP|1214488
996 ‎‡2  DNB|138958874
996 ‎‡2  SUDOC|234455462
996 ‎‡2  NUKAT|n 2019024889
996 ‎‡2  DBC|87097968923077
996 ‎‡2  LC|no2015043482
996 ‎‡2  LC|no2014138136
996 ‎‡2  BNF|17034165
996 ‎‡2  LC|no 00039616
996 ‎‡2  J9U|987007422017605171
996 ‎‡2  LC|n 2008031072
996 ‎‡2  JPG|500279149
996 ‎‡2  DNB|131591398
996 ‎‡2  LC|n 00104365
996 ‎‡2  BIBSYS|90684179
996 ‎‡2  LC|no2022053483
996 ‎‡2  LC|no2013014430
996 ‎‡2  ISNI|0000000038919988
996 ‎‡2  ISNI|0000000067829041
996 ‎‡2  J9U|987007309537505171
996 ‎‡2  NKC|ntk2015871332
996 ‎‡2  RERO|A026415019
996 ‎‡2  J9U|987011218681205171
996 ‎‡2  NTA|071369996
996 ‎‡2  LIH|LNB:BN_v_L;=B_o_
996 ‎‡2  ISNI|0000000075504095
996 ‎‡2  SUDOC|077008790
996 ‎‡2  NTA|362914966
996 ‎‡2  LC|no2018074315
996 ‎‡2  LC|n 81116395
996 ‎‡2  BIBSYS|6080206
996 ‎‡2  ISNI|0000000037424799
996 ‎‡2  LC|nr2002038705
996 ‎‡2  VLACC|000024113
996 ‎‡2  LC|no2019072752
996 ‎‡2  RERO|A003816298
996 ‎‡2  LC|n 88185081
996 ‎‡2  ISNI|0000000506039560
996 ‎‡2  J9U|987007523163005171
996 ‎‡2  BIBSYS|8009780
996 ‎‡2  DNB|1145650163
996 ‎‡2  ISNI|0000000083116770
996 ‎‡2  SUDOC|227281071
996 ‎‡2  SUDOC|244281661
996 ‎‡2  SUDOC|104531940
996 ‎‡2  ISNI|0000000037219357
996 ‎‡2  LC|no2019180486
996 ‎‡2  LC|nb2006024679
996 ‎‡2  LC|nb 98055836
996 ‎‡2  LC|n 2009060471
996 ‎‡2  SUDOC|245422331
996 ‎‡2  LC|n 2001111457
996 ‎‡2  NYNYRILM|31430
996 ‎‡2  LC|no2014089965
996 ‎‡2  BIBSYS|7022487
996 ‎‡2  CAOONL|ncf11420411
996 ‎‡2  LC|n 2001002114
996 ‎‡2  LC|n 84191716
996 ‎‡2  LC|n 93018195
996 ‎‡2  DNB|123292123
996 ‎‡2  DNB|1116965143
996 ‎‡2  BNF|16227661
996 ‎‡2  RERO|A003816293
996 ‎‡2  RERO|A003816290
996 ‎‡2  ISNI|0000000073873671
996 ‎‡2  RERO|A003816296
996 ‎‡2  RERO|A003816297
996 ‎‡2  RERO|A003816294
996 ‎‡2  BIBSYS|90351112
996 ‎‡2  ISNI|0000000451671584
996 ‎‡2  SUDOC|180644033
996 ‎‡2  DNB|1055488960
996 ‎‡2  ISNI|0000000036305552
996 ‎‡2  NDL|00806536
996 ‎‡2  LC|n 80005847
996 ‎‡2  DE633|pe30047524
996 ‎‡2  ISNI|0000000029255980
996 ‎‡2  LC|no2005048126
996 ‎‡2  NII|DA11795623
996 ‎‡2  SUDOC|240461541
996 ‎‡2  ISNI|0000000074575035
996 ‎‡2  ISNI|000000007631535X
996 ‎‡2  BIBSYS|1671431693129
996 ‎‡2  LC|nb2017011667
996 ‎‡2  LC|no2008078511
996 ‎‡2  J9U|987007356820405171
996 ‎‡2  RERO|A020316505
996 ‎‡2  ISNI|0000000455713040
996 ‎‡2  ISNI|0000000140201251
996 ‎‡2  N6I|vtls002407649
996 ‎‡2  J9U|987007425837305171
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏
998 ‎‡a  Scott, Mark G. H.‏ ‎‡2  SUDOC|164749365‏ ‎‡3  suggested‏ ‎‡3  title: (0.68, 'regulationofvecadherinexpressionanddynamicinendothelialpermeability', '100terminusregionofβarrestin1modulatesvecadherinexpressionandendothelialcellpermeability')‏